ABIOMED INC (ABMD)
US0036541003 - Common Stock
| TTM (2022-9-30) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 266.76M | 136.50M | 225.50M | 203.00M | 259.00M | |||
| Depreciation Amortization | 27.56M | 28.09M | 24.10M | 20.40M | 14.10M | |||
| Income Taxes - Deferred | -13.20M | 2.41M | 29.40M | 33.00M | -7.70M | |||
| Change In Working Capital | -23.26M | -30.20M | -17.40M | 8.00M | -38.80M | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | 94.73M | 61.76M | 48.70M | 9.70M | 5.30M | |||
| Other non cash items | -6.89M | 148.58M | 13.00M | 50.50M | 25.60M | |||
| OPERATING CASH FLOW | 250.98M | 285.39M | 274.60M | 314.90M | 252.20M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -33.76M | -35.76M | -53.40M | -44.00M | -44.00M | |||
| Other Investing Activity | -129.15M | -345.23M | -170.00M | -81.40M | -72.50M | |||
| INVESTING CASH FLOW | -162.91M | -380.99M | -223.30M | -125.50M | -116.50M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | -116.00M | 16.66M | 3.20M | -76.00M | 16.00M | |||
| Other Financing Activity | -19.53M | -18.86M | -11.30M | -41.70M | -71.80M | |||
| FINANCING CASH FLOW | -135.53M | -2.20M | -8.10M | -117.70M | -55.80M | |||
| Exchange Rate Effect | -12.08M | -2.09M | -2.80M | -400.00K | -1.90M | |||
| CHANGE IN CASH | -59.55M | -99.89M | 40.40M | 71.30M | 78.00M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 250.98M | 285.39M | 274.60M | 314.90M | 252.20M | |||
| Capital Expenditure | -33.76M | -35.76M | -53.40M | -44.00M | -44.00M | |||
| FREE CASH FLOW | 217.22M | 249.63M | 221.20M | 270.90M | 208.20M | |||
All data in USD